Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective-Reference-Cited by-同舟云学术

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective

Published:2021-01 Issue:1 Volume:3 Page:e71-e82
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Mackie Sarah L,Brouwer Elisabeth,Conway Richard,van der Geest Kornelis S M,Mehta Puja,Mollan Susan P,Neill Lorna,Putman Michael,Robinson Philip C,Sattui Sebastian E

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference47 articles.

1. A war on two fronts: cancer care in the time of COVID-19;Kutikov;Ann Intern Med,2020

2. Context, context, context: how has COVID-19 changed implementation globally and how can we ‘lock in' learning?;Swaithes;Rheumatology (Oxford),2020

3. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis;Mackie;Rheumatology (Oxford),2020

4. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis;Hellmich;Ann Rheum Dis,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling the opportunity for cost-savings or patient access with biosimilar adalimumab and tocilizumab: a European perspective;Journal of Medical Economics;2024-07-23

2. The spectrum of giant cell arteritis through a rheumatology lens;Eye;2024-06-19

3. Cranial involvement in giant cell arteritis;The Lancet Rheumatology;2024-06

4. Secondary Vasculitis Attributable to Post-COVID Syndrome;Cureus;2023-08-25

5. Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019;Rheumatic Disease Clinics of North America;2023-08